Literature DB >> 1709866

Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide.

M Schulz1, P Aichele, R Schneider, T H Hansen, R M Zinkernagel, H Hengartner.   

Abstract

The primary immune response of cytotoxic T lymphocytes in H-2d and H-2q mice to infection with lymphocytic choriomeningitis virus is directed mostly towards the common major T cell epitope of amino acids 112-132 on the viral nucleoprotein (NP). The molecules responsible for presentation of the T cell epitope NP112-132 are in both haplotypes the MHC class I L antigens (Ld, Lq). Truncations of the amino and carboxy termini of the NP 112-132 sequence revealed the nonapeptide RPQASGVYM (NP118-126) as a most effective peptide antigen, but even the tetrapeptide GVYM was recognized by CTL of both haplotypes in a class I antigen-restricted specificity. When tyrosine (Y) or methionine (M) were substituted with alanine, CTL recognition of the altered nonamer required 10(6) to 10(8) times higher peptide concentrations and in one case (Y----A on Ld) the peptide was not recognized at all. Up-modulation of the expression of Ld and Lq class I antigens as measured by flow cytometry correlated with the ability to present the peptide antigens. The only exception was peptide NP118-126 (M----A), which was recognized by T cells on L-Ld and L-Lq target cells but failed to up-regulate Ld and Lq antigens.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709866     DOI: 10.1002/eji.1830210513

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

1.  Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs.

Authors:  R Holtappels; M F Pahl-Seibert; D Thomas; M J Reddehase
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice.

Authors:  Lukas W Pfannenstiel; Samuel S K Lam; Leisha A Emens; Elizabeth M Jaffee; Todd D Armstrong
Journal:  Cell Immunol       Date:  2010-03-06       Impact factor: 4.868

3.  Induction of cytotoxic T-cell response by optimal-length peptides does not require CD4+ T-cell help.

Authors:  C Fayolle; U M Abdel-Motal; L Berg; E Deriaud; M Jondal; C Leclerc
Journal:  Immunology       Date:  1996-09       Impact factor: 7.397

4.  Uncovering subdominant cytotoxic T-lymphocyte responses in lymphocytic choriomeningitis virus-infected BALB/c mice.

Authors:  R G van der Most; R J Concepcion; C Oseroff; J Alexander; S Southwood; J Sidney; R W Chesnut; R Ahmed; A Sette
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Nondominant CD8 T cells are active players in the vaccine-induced antitumor immune response.

Authors:  Jennifer N Uram; Chelsea M Black; Emilee Flynn; Lanqing Huang; Todd D Armstrong; Elizabeth M Jaffee
Journal:  J Immunol       Date:  2011-02-23       Impact factor: 5.422

Review 6.  MHC ligands and peptide motifs: first listing.

Authors:  H G Rammensee; T Friede; S Stevanoviíc
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

7.  A cell-based MHC stabilization assay for the detection of peptide binding to the canine classical class I molecule, DLA-88.

Authors:  Peter Ross; Jennifer C Holmes; Gregory S Gojanovich; Paul R Hess
Journal:  Vet Immunol Immunopathol       Date:  2012-09-21       Impact factor: 2.046

8.  Characterization of the Ld-restricted cytotoxic T-lymphocyte epitope in the mouse hepatitis virus nucleocapsid protein.

Authors:  C Bergmann; M McMillan; S Stohlman
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

9.  Specificity of the H-2 L(d)-restricted cytotoxic T-lymphocyte response to the mouse hepatitis virus nucleocapsid protein.

Authors:  C C Bergmann; S A Stohlman
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

10.  Vaccination with a synthetic peptide modulates lymphocytic choriomeningitis virus-mediated immunopathology.

Authors:  M Battegay; S Oehen; M Schulz; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.